advertisement
Top-Nine of the American Glaucoma Society Annual Meeting
March 4-7, 2004, Sarasota, Florida, USA
Robert Noecker
- Ultra high speed Optical Coherence Tomography and Spectral OCT are being developed and may offer even better resolution and detail than other existing OCT technologies.
- Fluorescent Imaging of Amyloid in Eyes and Brains of Glaucomatous Rats After Injection of IV Soluble Dye indicates that amyloid accumulation occurs in eyes with glaucoma, and tracking amyloid may have diagnostic value.
- Mean central corneal thickness (CCT) among Caucasians and Africans was found to be 558 and 526 microns, respectively. In comparison, East Indians had mean CCT of 535 microns, much closer to African than Caucasian values.
- SLT was shown to be repeatable in patients, showing an average 20% reduction in IOP with the primary treatment, and a 15% drop with repeat treatment.
- There are low levels of hydrolysis product detected in the aqueous humor of patients treated with bimatoprost prior to cataract surgery.
- A new combination drug of travaprost and timolol, used once a day, appears to effectively lower IOP and is superior to the individual components at many timepoints.
- In patients who develop glaucoma after keratoplasty, surgeons should follow the standard glaucoma protocol, starting with medication, then moving to laser procedures and finally more invasive surgery.
- A portable noninvasive ultrasound device can provide surgeons with valuable information about Schlemm s canal. The device has the potential to increase scientists understanding of aqueous outflow, as well as to determine why some procedures work in certain patients but not others.
- With five years of follow-up, investigators found that the addition of 5-FU during surgery resulted in IOPs that were 5% lower than when no antimetabolites were used. Moreover, complications were less common in the 5-FU group, and the use of 5-FU did not appear to increase the risk of endophthalmitis.